An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2017.1409228
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 3, 2017
Authors
Publisher
Informa UK Limited